Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

Sofe-M

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 4, 2026 · PHASE 1 TRIAL

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

ClinicalTrials.gov

This is a Phase 1/1b/2 early-stage trial registration with no posted results; it describes planned enrollment and primary endpoints only, reflecting hypothesis-generating and dose-finding work typical of first-in-human oncology studies.

PreliminaryEli Lilly and Company Itraconazole Ovarian Neoplasms

Reported

Planned enrollment575

Study phasePhase 1a/1b/2

Phase 1a primary outcomeRecommended phase 2 dose (RP2D) of Sofe-M a…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support